Table 3.
Risk of rapid decline of eGFR according to the status of baPWV and hfPWV in subset with both baPWV and hfPWV data.
| Total (n = 1182) | Univariate | Multivariate | ||
|---|---|---|---|---|
| OR (95% CI) | P | Adjusted OR (95% CI) | P | |
| baPWV (m/s) | 1.061 (1.022–1.101) | 0.002 | 1.084 (1.030–1.141) | 0.002 |
| hfPWV (m/s) | 1.062 (1.014–1.112) | 0.010 | 1.029 (0.961–1.103) | 0.408 |
| High-baPWV (yes vs. no) | 1.770 (1.305–2.401) | <0.001 | 1.872 (1.269–2.761) | 0.002 |
| High-hfPWV (yes vs. no) | 1.642 (1.220–2.210) | 0.001 | 1.389 (0.936–2.061) | 0.103 |
| Combined groups (vs. low-ba/low-hf) | 0.001 | 0.015 | ||
| high-ba/low-hf | 1.360 (0.853–2.168) | 0.197 | 1.670 (0.968–2.880) | 0.065 |
| low-ba/high-hf | 1.220 (0.790–1.883) | 0.370 | 1.072 (0.626–1.835) | 0.801 |
| high-ba/high-hf | 2.177 (1.493–3.175) | <0.001 | 2.100 (1.280–3.447) | 0.003 |
eGFR, estimated glomerular filtration rate; OR, odds ratio; CI, confidence interval; hfPWV, heart-femoral PWV; baPWV, brachial-ankle pulse wave velocity.
OR and its CI were calculated using logistic regression analysis. In multivariate analysis, covariates were age, sex and variables with P < 0.05 in univariate logistic regression analysis for the rapid decline of eGFR (diabetes, causes of chronic kidney diseases, pulse pressure, eGFR, logarithm of urine protein-to-creatinine ratio, albumin, cholesterol, hemoglobin, serum calcium level, and beta blocker use).